A venture capital and private equity firm investing in biotechnology companies.
Their exited investments include CRISPR Therapeutics, Progyny, Propeller Health, Genocea Biosciences, Bicycle Therapeutics, Dicerna Pharmaceuticals, Turning Point Therapeutics, ZappRx, Morphic Therapeutic, Translate Bio and Spero Therapeutics.
Our mission is to translate ground-breaking technologies into next generation medicines to benefit patients with significant unmet medical needs.